SC 13G | 2024-02-14 | ARMISTICE CAPITAL, LLC | Hepion Pharmaceuticals, Inc. | 418,000 | 8.7% | EDGAR |
SC 13G/A | 2022-02-14 | Altium Capital Management LP | Hepion Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | Hepion Pharmaceuticals, Inc. | 3,326,017 | 4.4% | EDGAR |
SC 13G/A | 2022-01-19 | Empery Asset Management, LP | Hepion Pharmaceuticals, Inc. | 335,745 | 0.4% | EDGAR |
SC 13G/A | 2022-01-04 | SABBY MANAGEMENT, LLC | Hepion Pharmaceuticals, Inc. | 603,812 | 0.8% | EDGAR |
SC 13G | 2021-02-24 | Altium Capital Management LP | Hepion Pharmaceuticals, Inc. | 4,500,000 | 5.9% | EDGAR |
SC 13G | 2021-02-19 | SABBY MANAGEMENT, LLC | Hepion Pharmaceuticals, Inc. | 5,000,000 | 6.6% | EDGAR |
SC 13G | 2021-02-18 | Empery Asset Management, LP | Hepion Pharmaceuticals, Inc. | 4,000,000 | 5.2% | EDGAR |
SC 13G/A | 2021-02-16 | CVI Investments, Inc. | Hepion Pharmaceuticals, Inc. | 420,000 | 1.3% | EDGAR |
SC 13G | 2021-02-10 | VANGUARD GROUP INC | Hepion Pharmaceuticals, Inc. | 1,728,604 | 6.0% | EDGAR |
SC 13G/A | 2021-02-09 | Hudson Bay Capital Management LP | Hepion Pharmaceuticals, Inc. | 295,880 | 0.9% | EDGAR |
SC 13G/A | 2021-01-20 | Empery Asset Management, LP | Hepion Pharmaceuticals, Inc. | 335,745 | 1.0% | EDGAR |
SC 13G/A | 2021-01-07 | SABBY MANAGEMENT, LLC | Hepion Pharmaceuticals, Inc. | 583,333 | 2.0% | EDGAR |
SC 13G/A | 2020-12-28 | HIRSCHMAN ORIN | Hepion Pharmaceuticals, Inc. | 1,173,230 | 4.0% | EDGAR |
SC 13G | 2020-12-09 | HIRSCHMAN ORIN | Hepion Pharmaceuticals, Inc. | 2,000,000 | 6.9% | EDGAR |
SC 13G | 2020-12-02 | Empery Asset Management, LP | Hepion Pharmaceuticals, Inc. | 2,000,000 | 6.9% | EDGAR |
SC 13G | 2020-12-02 | SABBY MANAGEMENT, LLC | Hepion Pharmaceuticals, Inc. | 2,000,420 | 6.9% | EDGAR |
SC 13G/A | 2020-02-14 | Anson Funds Management LP | Hepion Pharmaceuticals, Inc. | 181,394 | 4.9% | EDGAR |
SC 13G/A | 2020-02-10 | CVI Investments, Inc. | Hepion Pharmaceuticals, Inc. | 183,536 | 5.0% | EDGAR |
SC 13G | 2020-02-05 | Hudson Bay Capital Management LP | Hepion Pharmaceuticals, Inc. | 293,648 | 7.8% | EDGAR |